Denmark drops Johnson & Johnson shot from nationwide vaccine rollout

Issued on:

Denmark mentioned Monday it will not embody the Covid-19 vaccine from US drugmaker Johnson & Johnson in its nationwide vaccination marketing campaign, citing worries over critical uncomfortable side effects involving blood clots. 

“The Danish Well being Authority has concluded that the advantages of utilizing the Covid-19 vaccine from Johnson & Johnson don’t outweigh the chance of inflicting the attainable hostile impact… in those that obtain the vaccine,” the authority mentioned in an announcement.

“Due to this fact, the Danish Well being Authority will proceed the Danish mass vaccination programme towards Covid-19 with out the Covid-19 vaccine from Johnson & Johnson,” it added.

The transfer comes after the Nordic nation final month stopped utilizing AstraZeneca’s vaccine altogether over a possible hyperlink to a uncommon however critical type of blood clot.

The rollout of J&J’s vaccine has additionally been delayed elsewhere in Europe over related clotting issues, although the WHO and European Medicines Company (EMA) have each authorised the vaccine. 

The European medicines watchdog mentioned its security committee had concluded {that a} warning about uncommon blood clots with low platelets should be added to the vaccine’s labels, simply as was required of AstraZeneca. J&J mentioned in a information launch that it will adjust to that measure.

Excluding the J&J vaccine, which accounts for round a 3rd of Denmark’s whole contracted provides of Covid-19 photographs, might considerably delay the nation’s vaccination calendar.

(FRANCE 24 with AFP and REUTERS)

Leave a Reply

%d bloggers like this: